HealthStream
HSTM
32.10
+0.79
+2.52%
HealthStream
US · HSTM
#3266 by market cap
32.10
+0.79
+2.52%
Live - 5344 symbols - heartbeat 316s ago
· 2026-10-08 08:03
Pre-market
32.37
+0.84%
After-hours
32.10
0.00%
- Market cap
- 982.13M
- P/E (TTM)i
- 44.58
- P/Bi
- 2.75
- EPSi
- 0.61
- Div yieldi
- 0.41%
- 52W posi
- 98%
Reader sentiment
Are you bullish or bearish on HSTM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.58, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.26% YoY
Margins
- Gross margin
- 64.74%
- Operating margin
- 6.66%
- Net margin
- 6.03%
Key ratios & quality
- PEG ratioi
- 2.99
- Altman Z-Scorei
- 4.58
PEG uses trailing P/E against the 3-year net income growth rate (14.90%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 231.62M | 254.11M | 244.83M | 256.71M | 266.83M | 279.06M | 291.65M | 304.06M |
| Gross profit | 135.60M | 150.22M | 155.49M | 165.68M | 175.68M | 184.04M | 193.71M | 196.86M |
| Selling & admin expenses | 70.15M | 78.52M | 77.18M | 79.15M | 81.01M | 81.41M | 82.29M | 82.16M |
| Research & development | 25.74M | 29.11M | 32.31M | 41.66M | 44.28M | 45.54M | 48.89M | 50.98M |
| Operating profit | 15.49M | 14.72M | 15.82M | 8.06M | 12.45M | 16.02M | 21.29M | 20.24M |
| Pretax profit | 16.58M | 17.93M | 17.82M | 7.77M | 15.59M | 18.51M | 24.80M | 23.22M |
| Tax | 3.32M | 3.73M | 3.73M | 1.92M | 3.49M | 3.30M | 4.80M | 4.88M |
| Net profit | 32.22M | 15.77M | 14.09M | 5.85M | 12.09M | 15.21M | 20.01M | 18.34M |
| Basic EPS | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Diluted EPS | 1.00 | 0.49 | 0.44 | 0.18 | 0.39 | 0.50 | 0.66 | 0.61 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 73.49M | 74.40M | 76.47M | 79.71M | 81.20M | 83.73M |
| Gross profit | 48.00M | 48.03M | 49.97M | 50.86M | 53.45M | 54.72M |
| Selling & admin expenses | 20.82M | 19.21M | 19.47M | 22.66M | 20.96M | 21.54M |
| Research & development | 12.05M | 12.07M | 12.11M | 14.76M | 13.61M | 13.58M |
| Operating profit | 4.38M | 5.89M | 7.57M | 2.40M | 7.51M | 8.32M |
| Pretax profit | 5.25M | 6.87M | 8.25M | 2.85M | 7.82M | 8.70M |
| Tax | 916.00K | 1.48M | 2.17M | 317.00K | 1.91M | 2.03M |
| Net profit | 4.33M | 5.39M | 6.09M | 2.53M | 5.91M | 6.67M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.14 | 0.18 | 0.20 | 0.09 | 0.20 | 0.23 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 241.43M | 224.57M | 114.73M | 106.85M | 114.38M | 130.21M | 153.12M | 119.66M |
| Cash & ST investments | 168.82M | 172.87M | 46.49M | 51.95M | 53.91M | 71.13M | 97.22M | 57.00M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 441.95M | 489.54M | 500.31M | 486.75M | 497.74M | 499.94M | 510.77M | 520.37M |
| Total current liabilities | 106.85M | 105.19M | 119.44M | 100.35M | 117.21M | 118.36M | 115.69M | 124.15M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 123,001,000.00 | 151,376,000.00 | 166,251,000.00 | 147,734,000.00 | 163,677,000.00 | 159,190,000.00 | 151,411,000.00 | 166,351,000.00 |
| Total equity | 318.95M | 338.17M | 334.06M | 339.02M | 334.06M | 340.75M | 359.36M | 354.02M |
| Retained earnings | 32.37M | 48.14M | 62.28M | 68.12M | 80.21M | 92.37M | 108.97M | 123.59M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 169.72M | 144.40M | 147.57M | 119.66M | 133.02M | 130.22M |
| Cash & ST investments | 113.32M | 90.62M | 92.59M | 57.00M | 66.50M | 66.73M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 524.04M | 500.15M | 499.93M | 520.37M | 527.44M | 521.60M |
| Total current liabilities | 125.86M | 115.38M | 112.50M | 124.15M | 136.51M | 122.64M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 161,228,000.00 | 149,581,000.00 | 150,737,000.00 | 166,351,000.00 | 175,449,000.00 | 164,994,000.00 |
| Total equity | 362.81M | 350.57M | 349.19M | 354.02M | 351.99M | 356.61M |
| Retained earnings | 112.36M | 116.80M | 121.97M | 123.59M | 128.47M | 134.11M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 43.25M | 65.66M | 35.87M | 42.39M | 51.19M | 63.97M | 57.66M | 63.32M |
| Depreciation & amortization | 24.23M | 27.87M | 30.19M | 36.81M | 37.95M | 41.08M | 41.24M | 43.48M |
| Free cash flow | 24.80M | 29.15M | 17.07M | 17.04M | 26.09M | 35.96M | 29.52M | 31.16M |
| Dividends paid | -32.36M | -58.00K | -40.00K | -19.00K | 0 | -3.06M | -3.40M | -3.73M |
| Stock buybacks / issuance | 0 | 0 | -20.02M | -5.01M | -23.14M | -8.93M | 0 | -30.02M |
| Ending cash balance | 134.32M | 131.54M | 36.57M | 46.91M | 46.02M | 40.33M | 59.47M | 36.16M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 27.07M | 5.02M | 18.03M | 13.19M | 27.14M | 13.43M |
| Depreciation & amortization | 10.76M | 10.87M | 10.82M | 11.04M | 11.37M | 11.28M |
| Free cash flow | 18.23M | -4.00M | 10.51M | 6.42M | 19.67M | 5.00M |
| Dividends paid | -943.00K | -947.00K | -919.00K | -920.00K | -1.03M | -1.03M |
| Stock buybacks / issuance | 0 | -18.12M | -6.90M | -5.00M | -6.72M | -2.58M |
| Ending cash balance | 77.29M | 52.10M | 53.54M | 36.16M | 48.71M | 46.17M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 10.41 | 4.80 | 4.19 | 1.74 | 3.59 | 4.51 | 5.72 | 5.14 |
| ROA %i | 7.55 | 3.39 | 2.85 | 1.18 | 2.46 | 3.05 | 3.96 | 3.56 |
| ROIC %i | 10.41 | 4.39 | 3.85 | 1.61 | 3.35 | 4.24 | 4.58 | 4.21 |
| 5-year avg ROE %i | 5.11 | 4.76 | 4.83 | 4.91 | 4.95 | 3.77 | 3.95 | 4.14 |
| EBIT margin %i | 6.69 | 5.79 | 6.46 | 3.14 | 4.67 | 5.74 | 7.30 | 6.66 |
| FCF / sales %i | 10.71 | 11.47 | 6.97 | 6.64 | 9.78 | 12.89 | 10.12 | 10.25 |
| Current ratioi | 2.26 | 2.14 | 0.96 | 1.06 | 0.98 | 1.10 | 1.32 | 0.96 |
| Quick ratioi | 1.96 | 1.93 | 0.78 | 0.87 | 0.82 | 0.93 | 1.15 | 0.77 |
| Debt / assetsi | 0.00 | 6.28 | 5.69 | 5.38 | 4.69 | 4.05 | 3.40 | 2.82 |
| LT debt / equityi | -- | 9.09 | 8.53 | 7.72 | 6.98 | 5.94 | 4.83 | 4.15 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 3.48 | 9.77 | 4.44 | 3.49 | 1.64 | 4.46 | 4.34 | 4.45 |
| Net income CAGR (3Y) %i | 55.18 | 61.34 | 12.10 | -43.39 | -8.47 | 2.59 | 50.71 | 14.90 |
| FCF CAGR (3Y) %i | 8.23 | 40.77 | -18.56 | -11.76 | -3.63 | 28.19 | 20.10 | 6.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.40 | 5.81 | 5.87 | 5.14 | 5.57 | 6.00 |
| ROA %i | 3.69 | 4.07 | 4.13 | 3.56 | 3.79 | 4.15 |
| ROIC %i | 4.30 | 4.68 | 4.82 | 4.21 | 4.76 | 5.27 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.83 | 7.27 | 7.54 | 6.66 | 7.50 | 8.04 |
| FCF / sales %i | 11.82 | 10.44 | 9.73 | 10.25 | 10.45 | 12.95 |
| Current ratioi | 1.35 | 1.25 | 1.31 | 0.96 | 0.97 | 1.06 |
| Quick ratioi | 1.19 | 1.06 | 1.12 | 0.77 | 0.81 | 0.84 |
| Debt / assetsi | 3.18 | 3.18 | 3.06 | 2.82 | 2.67 | 2.57 |
| LT debt / equityi | 4.59 | 4.53 | 4.38 | 4.15 | 4.00 | 3.77 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Subscription services is the largest reported line at 95.53% of revenue, across 2 reported segments.
- The next-largest line, Professional services, is a distant second at 4.47% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Subscription services95.53%
Professional services4.47%
Quote time 2026-10-08 08:03:51 · For reference only, not investment advice and not tailored to your situation.